Ameresco (AMRC) Tops Q1 EPS by 14c

Ameresco (NYSE: AMRC) reported Q1 EPS of $0.16, $0.14 better than the analyst estimate of $0.02. Revenue for the quarter came in at $167.4 million versus the consensus estimate of $140.03 million.

For earnings history and earnings-related data on Ameresco (AMRC) click here.

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• ADC Therapeutics SA (ADCT) Tops Q2 EPS by 11c
• Paysafe Limited (PSFE) Misses Q2 EPS by 43c; offers guidance